Literature DB >> 25430703

Autoantibody response and pregnancy-related pathology induced by combined LPS and tetanus toxoid hyperimmunization in BALB/c and C57BL/6 mice.

Vladimir Petrušić1, Nevena Todorović, Irena Živković, Rajna Dimitrijević, Lina Muhandes, Irena Rajnpreht, Ljiljana Dimitrijević.   

Abstract

Recent data concerning antiphospholipid syndrome (APS) induction have shown that β2-glycoprotein I (β2GPI) binds lipopolysaccharide (LPS), which results in conformational changes, exposition of a cryptic epitope and possible pathological anti-β2GPI antibody production. In order to investigate the effects of LPS on the induction of APS-related pathology, we performed hyperimmunization of BALB/c and C57BL/6 mice with LPS, alone or in combination with tetanus toxoid (TTd), a protein structurally similar to β2GPI. We report that, although high affinity pathological anti-β2GPI antibodies were produced in all groups of animals, the reproductive pathology was recorded only in mice that received both LPS and TTd, implying on the important roles of both infections and molecular mimicry in APS pathogenesis. Moreover, APS-related reproductive pathology was more pronounced in BALB/c (lowered fertility and fecundity) than C57BL/6 mice (lowered fecundity), which correlated well with the disruption in natural antibody network observed in BALB/c mouse strain.

Entities:  

Keywords:  antiphospholipid syndrome; fertility; molecular mimicry; natural antibodies; β2-glycoprotein I

Mesh:

Substances:

Year:  2014        PMID: 25430703     DOI: 10.3109/08916934.2014.961061

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  2 in total

1.  Adjuvants- and vaccines-induced autoimmunity: animal models.

Authors:  Jiram Torres Ruiz; Luis Luján; Miri Blank; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2017-02       Impact factor: 4.505

Review 2.  Autoimmune reaction after anti-tetanus vaccination-description of four cases and review of the literature.

Authors:  N Ruhrman-Shahar; J Torres-Ruiz; P Rotman-Pikielny; Y Levy
Journal:  Immunol Res       Date:  2017-02       Impact factor: 4.505

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.